Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Peter

Showing results (661-670 of 815) with videos related to

Pageof 82
Sort By:
JCO Precision Oncology|October 23, 2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and SurvivalPratik Chandra, Yi Song, Esther Drill, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Whole genome sequencing of a family with autosomal dominant features within the oculoauriculovertebral spectrumA L Petrin, L A Machado-Paula, A Hinkle, et al.
JCO Precision Oncology|July 10, 2024
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and OutcomeWilliam A Preston, Esther Drill, Thomas Boerner, et al.
Annals of Surgery|June 16, 2023
Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological OutcomesAlessandra Pulvirenti, Haley F Hauser, Laura M Fiedler, et al.
The Oncologist|May 6, 2021
Opportunities for Improvement in the Administration of Neoadjuvant Chemotherapy for T4 Breast Cancer: A Comparison of the U.S. and NigeriaAnya Romanoff, Olalekan Olasehinde, Debra A Goldman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 27, 2019
Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional studyReed I Ayabe, Raja R Narayan, Samantha M Ruff, et al.
Annals of Surgical Oncology|September 21, 2020
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon CancerJohn M Creasy, Kristen M Cunanan, Jayasree Chakraborty, et al.
Annals of Surgical Oncology|September 15, 2016
Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal TumorSer Yee Lee, Brian K P Goh, Eran Sadot, et al.
BMC Palliative Care|May 27, 2026
"What you don't have, you can't give": a mixedmethods assessment of healthcare professionals' palliative care knowledge and attitudes in NigeriaSharif Folorunso, Betel Yibrehu, Erica J Mann, et al.
Journal of the American College of Surgeons|April 27, 2016
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional EvaluationJulie N Leal, Alexsander K Bressan, Neeta Vachharajani, et al.
Pageof 82

Showing results (661-670 of 815) with videos related to

Sort By:
Pageof 82
JCO Precision Oncology|October 23, 2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and SurvivalPratik Chandra, Yi Song, Esther Drill, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Whole genome sequencing of a family with autosomal dominant features within the oculoauriculovertebral spectrumA L Petrin, L A Machado-Paula, A Hinkle, et al.
JCO Precision Oncology|July 10, 2024
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and OutcomeWilliam A Preston, Esther Drill, Thomas Boerner, et al.
Annals of Surgery|June 16, 2023
Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological OutcomesAlessandra Pulvirenti, Haley F Hauser, Laura M Fiedler, et al.
The Oncologist|May 6, 2021
Opportunities for Improvement in the Administration of Neoadjuvant Chemotherapy for T4 Breast Cancer: A Comparison of the U.S. and NigeriaAnya Romanoff, Olalekan Olasehinde, Debra A Goldman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 27, 2019
Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional studyReed I Ayabe, Raja R Narayan, Samantha M Ruff, et al.
Annals of Surgical Oncology|September 21, 2020
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon CancerJohn M Creasy, Kristen M Cunanan, Jayasree Chakraborty, et al.
Annals of Surgical Oncology|September 15, 2016
Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal TumorSer Yee Lee, Brian K P Goh, Eran Sadot, et al.
BMC Palliative Care|May 27, 2026
"What you don't have, you can't give": a mixedmethods assessment of healthcare professionals' palliative care knowledge and attitudes in NigeriaSharif Folorunso, Betel Yibrehu, Erica J Mann, et al.
Journal of the American College of Surgeons|April 27, 2016
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional EvaluationJulie N Leal, Alexsander K Bressan, Neeta Vachharajani, et al.
Pageof 82